Organon
About Organon
Organon is a Dutch pharmaceutical company started in Oss the Netherlands. It is famous for 'the Pil' a birthcontrol pil. Organon grew as a company and was taken over by Schering plough and later on by Merck and continues as MSD in the Netherlands. In the old days the compant was great, it used to be 'gezellig' !
Recent News
RFK’s Food Pyramid Is a Win for Industry, Not Health
Sun Pharma to Acquire Organon for ~$11.75B
Sun Pharma to Acquire Organon for $11.75 Bn, Marking India's Largest Overseas Pharma Deal
Blue Owl Expands Real Estate with Sila Realty Acquisition – Merger Arbitrage Mondays
Editorial. Costly Remedy
Biotech ETFs Clash on Fees: Invesco’s IBBQ Beats State Street’s XPH on Cost and Yield
C&EN Weekly Chemistry News Quiz, May 1
Sun Pharma Explores Funding Mix for $12 Billion Organon Deal
SBI in $1 Billion Funding for Sun Pharma’s US Deal
Pharma and Biotech M&As 2026 Deal Watcher
Stock Market Highlights: Sensex, Nifty Rebound, Snap Three-Day Losing Streak on IT, Sun Pharma Rally
Henlius Receives US FDA IND Clearance for HLX05-N (Biosimilar, Erbitux)
India-Based Companies Announce a Record $20B Worth of US Investments
Dilip Shanghvi-Led Sun Pharma's Most Expensive M&A Deal Signals Fading Allure of US Generics Business
Sun Pharma to Acquire Organon for $12 Billion, Its Largest U.S. Deal Yet
Citi CEO Jane Fraser Accelerates Cultural Overhaul with New Executive Team
BIO Panel at HERS Explores Women’s Health Biotech Ecosystem
Henlius and Organon Gain EC Approval for Pertuzumab Biosimilar
Sun Pharma Q4 Net Profit up 26 per Cent
Henlius and Organon Receive the EC Approval for Poherdy (Biosimilar, Perjeta)
Sun Pharma to Acquire Organon for $11.75 Billion, Expanding B2B Drug Portfolio
India’s Pharma Industry Is Going Global. But Can It Catch up to China?
Organon to Present New Research on Access and Value at ISPOR 2026
How Big Is Organon’s Biosimilar Push for Sun Pharma?
Top Biotech Deals in April 2026
Sun Pharma to Acquire Organon for $11.75 B, Boosting Women’s Health and Biosimilars
Sun Pharma to Buy Organon for $11.75B in Major Portfolio Expansion
Morning Brief Podcast: Sun–Organon: The Scope, Risks, and Future of India's Biggest Pharma Deal
‘Orchestra of Therapies’ Required for Most SSc Patients
Asia Is Quietly and Quickly Buying up America
Nifty Snaps Three-Day Losing Streak, Climbs 195 Points; Midcaps Lead the Charge